Dr. Ramya Dinnekere Ravi

QUALIFICATION:

BACHELOR OF MEDICINE AND BACHELOR OF SURGERY (MBBS) 2015

Hassan Institute of Medical Sciences (HIMS)

Rajiv Gandhi University of Health Sciences (RGUHS), Karnataka, India.

DOCTOR OF MEDICINE (MD) IN OBSTETRICS AND GYNAECOLOGY 2018

Postgraduate Institute of Medical Education and Research (PGIMER)

Chandigarh, India.

MASTER OF CHIRURGIAE (MCh) GYNAECOLOGIC ONCOLOGY 2023

St. John’s Medical College and Hospital, Bengaluru

Rajiv Gandhi University of Health Sciences (RGUHS), Karnataka, India.

EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY (ESGO) certification 2023

European Society of Gynaecological Oncology certification in gynaecological oncology 2023 at Turkey.

FELLOWSHIP IN MINIMAL ACCESS SURGERY (FMAS) 2024

The Association of Minimal Access Surgeons of India

COURSES AND CERTIFICATIONS:

• International Society for Study of Pleura and Peritoneum (ISSPP) certified PIPAC Training Course and Workshop 2024. 

• ESGO (European Society Of Gynaecological Oncology)  exam- certification in Gynaecological Oncology with distinction 2023. 

• Training in Gynec Endoscopy, Maharashtra 2023. 

• Rapid Epibio ( Epidemiology and Biostatistics for synopsis submission)- SJMCH 2020. 

• IGCS- Palliative care certification program 2022. 

• IGCS- Preinvasive Disease Program (phase 1 &2) 2022. 

• Basic Course in Biomedical Research- ICMR 2022. 

• Neonatal Resuscitation Programme, February 2016. 

• Basic life support, November 2016.

EXPERIENCE

Junior resident (Jan 2016 – Dec 2018)

Department of obstetrics and gynaecology,

PGIMER Chandigarh.

Registrar (Jul 2019 – Sept 2019)

Department of Obstetrics and Gynaecology,

Bangalore Baptist Hospital, Bengaluru.

Senior resident (Sept 2019- Feb 2023)

Department of Gynaecological Oncology,

St. John’s Medical College and Hospital, Bengaluru.

Consultant Gynaecological Oncology (Aug 2023- present)

REGISTRATION AND MEMBERSHIPS:

REGISTRATION:

• MBBS, MD, MCh: Reg. No.109239, Karnataka Medical Council. (KMC 109239)

MEMBERSHIPS:

• Life Member of the Indian Medical Association (IMA).
• Life member of Association of Gynaecological Oncologists of India (AGOI)
• Member of European Society of Gynaecological Oncology (ESGO)
• Member of American Society of Clinical Oncology (ASCO)
• Member of International Gynaecological Cancer Society (IGCS)
• Member of Federation of Obstetric and Gynaecological Societies of India (FOGSI)

Roles: Zonal representative member (2023 -2025) Karnataka State Chapter- AGOI

AWARDS, RESEARCH AND PUBLICATIONS:

DOCTORAL THESIS TITLE:

“A RANDOMIZED CLINICAL TRIAL OF LEVONORGESTREL INTRA UTERINE SYSTEM WITH OR WITHOUT METFORMIN FOR TREATMENT OF ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA” PGIMER, Chandigarh.

PRESENTATIONS:

International Conferences:

• RCOG World Congress, London June 2019. I poster: “A randomized clinical trial of levonorgestrel intra uterine system with or without metformin for treatment of endometrial hyperplasia without atypia”

National Conference:

• AGOICON 202ONE- 28th Annual conference of AGOI. Poster presentation: Impact of COVID-19 pandemic on patients with gynaecological cancers receiving chemotherapy.

• AGOICON 202ONE- 28th Annual conference of AGOI- YGOG. Oral Paper presentation: The prognostic role of omental, ovarian chemotherapy response score and Ca125 in predicting survival in patients with tubo-ovarian high-grade serous carcinoma / primary peritoneal carcinoma receiving neoadjuvant chemotherapy.

Regional Conference:

• Workshop CME and Annual meeting of Obstetrics and Gynaecological Society of Northern India, Chandigarh, March 2018- Poster presentation: “POSTPARTUM ATYPICAL HAEMOLYTIC UREMIC SYNDROME”

• KSCAGOICON-2020- ‘Grapes and more grapes’- Oral paper presentation: IS CHEMOTHERAPY RESPONSE SCORE A PREDICTOR OF PLATINUM SENSITIVITY?

• KSCAGOICON-2021- ‘Adolescent and Young Adult- Gynec cancers’-Oral paper presentation: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH GYNAECOLOGICAL CANCERS RECEIVING CHEMOTHERAPY.

PUBLICATIONS:

• Asian Pacific Journal of Cancer Prevention-

A randomized clinical trial of Levonorgestrel intrauterine system with or without Metformin for treatment of Endometrial Hyperplasia without atypia in Indian women.

DOI: 10.31557/APJCP.2021.22.3.983

• Indian Journal Of Cancer (manuscript accepted for publication)

The prognostic role of omental, ovarian chemotherapy response score and CA125 in predicting survival in patients with tubo-ovarian high-grade serous carcinoma / primary peritoneal carcinoma receiving neoadjuvant chemotherapy.

• South Asian Journal of Cancer

Paraneoplastic Syndromes Associated with Gynecologic Neoplasms: Experience from a Tertiary Care Center in South India.

DOI https://doi.org/10.1055/s-0043-1772223

AWARDS & RECOGNITIONS:

• Best poster award for poster titled “Postpartum Atypical Haemolytic Uremic Syndrome” at Workshop CME and Annual meeting of Obstetrics and Gynaecological Society of Northern India. March 2018.

• Secured 3rd place – KSCAGOICON-2020- ‘Grapes and more grapes’- Oral paper presentation: IS CHEMOTHERAPY RESPONSE SCORE A PREDICTOR OF PLATINUM SENSITIVITY?

• Secured 3rd place – KSCAGOICON-2021- ‘Adolescent and Young Adult- Gynec cancers’ Oral paper presentation: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH GYNAECOLOGICAL CANCERS RECEIVING CHEMOTHERAPY.

• Secured highest marks in MD Obstetrics and Gynaecology final exam Dec 2018, PGIMER Chandigarh.

• Award for securing highest marks in Forensic Medicine in MBBS second year RGUHS University exams, HIMS, Hassan, Karnataka, India.

• Received Short term research scholarship grant for undergraduate students from RSSDI Karnataka chapter for project “A community-based study on prevalence and complication of diabetes as co-morbidity in pulmonary tuberculosis patients of Hassan district”